Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

TuHURA Biosciences, Inc. - Common Stock (NQ:HURA)

0.9700 +0.0100 (+1.04%)
Streaming Delayed Price Updated: 10:06 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 44,604
Open 0.9700
Bid (Size) 0.9640 (500)
Ask (Size) 0.9790 (300)
Prev. Close 0.9600
Today's Range 0.9631 - 1.000
52wk Range 0.9300 - 5.500
Shares Outstanding 1,746,408
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Keep an eye on the top gainers and losers in Tuesday's session. ↗
Looking for insights into the US markets one hour before the close of the markets on Tuesday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
News headline image
What's going on in today's session ↗
Wondering how the US markets performed in the middle of the day on Tuesday? Discover the movers and shakers of today's session in our comprehensive analysis. 
Via Chartmill

Performance

YTD
-76.4%
-76.4%
1 Month
-48.4%
-48.4%
3 Month
-59.4%
-59.4%
6 Month
-62.3%
-62.3%
1 Year
-76.6%
-76.6%

More News

Read More
News headline image
Traders are paying attention to the gapping stocks in Tuesday's session. ↗
Via Chartmill
News headline image
TuHURA Biosciences, Inc. to Present at the 37th Annual ROTH Conference
Via ACCESS Newswire
News headline image
TuHURA Biosciences, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
Via ACCESS Newswire
News headline image
TuHURA Biosciences, Inc. Enters into Definitive Merger Agreement to Acquire Kineta, Inc.
Via ACCESSWIRE
News headline image
TuHURA R&D Jumps 75% in Q2 ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
Via Chartmill
News headline image
Florida Rep. Laurel Lee Sold Up to $265K Worth of Alibaba Gr Hldgs Stock ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Via Benzinga
News headline image
Tuhura Biosciences Surges After-Hours As Investors Bet On Kineta Merger, Cancer Drug Pipeline ↗
Via Stocktwits
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
Via Benzinga
News headline image
These stocks are moving in today's pre-market session ↗
Via Chartmill
News headline image
12 Health Care Stocks Moving In Wednesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
Via Benzinga
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
Via Benzinga
News headline image
TuHURA Biosciences, Inc Appoints Craig L. Tendler M.D., Former Vice President, Oncology Clinical Development, Diagnostics, and Global Medical Affairs, Johnson & Johnson Innovative Medicine Research & Development, to its Board of Directors
Via ACCESS Newswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VTS and HURA on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PFIE, ML, HURA, KANT on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ML, PDCO, HURA, KANT on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
HURA Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of TuHURA Biosciences, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗
Via Benzinga
News headline image
TuHURA Biosciences, Inc. (Nasdaq: HURA) Outlines Development Pathway for Single Phase 3 Accelerated Approval Registration Trial in First Line Treatment of Advanced or Metastatic Merkel Cell Carcinoma and Provides Business Update
Via ACCESSWIRE

Frequently Asked Questions

Is TuHURA Biosciences, Inc. - Common Stock publicly traded?
Yes, TuHURA Biosciences, Inc. - Common Stock is publicly traded.
What exchange does TuHURA Biosciences, Inc. - Common Stock trade on?
TuHURA Biosciences, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for TuHURA Biosciences, Inc. - Common Stock?
The ticker symbol for TuHURA Biosciences, Inc. - Common Stock is HURA on the Nasdaq Stock Market
What is the current price of TuHURA Biosciences, Inc. - Common Stock?
The current price of TuHURA Biosciences, Inc. - Common Stock is 0.9700
When was TuHURA Biosciences, Inc. - Common Stock last traded?
The last trade of TuHURA Biosciences, Inc. - Common Stock was at 12/16/25 10:06 AM ET
What is the market capitalization of TuHURA Biosciences, Inc. - Common Stock?
The market capitalization of TuHURA Biosciences, Inc. - Common Stock is 1.69M
How many shares of TuHURA Biosciences, Inc. - Common Stock are outstanding?
TuHURA Biosciences, Inc. - Common Stock has 2M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.